Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle

Biochimica et Biophysica Acta - General Subjects

Volumn 1722, Issue 2, 2005, Pages 116-123

  Grasso, Emanuela ^a   Longo, Vincenzo ^b   Coceani, Flavio ^a,b   Gervasi, Pier Giovanni ^b  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Cattle; Coronary artery; Cytochrome P450; Liver; Metabolism of xenobiotic; Vasoregulation

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 2E; CYTOCHROME P450 2J; CYTOCHROME P450 3A; CYTOCHROME P450 4A; ISOPROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CATALYSIS; CATTLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBSTRATE; FLUORESCENCE; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TISSUE; WESTERN BLOTTING;

EID: 14544294886     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2004.11.018     Document Type: Article

References (33)

1. D.R. Nelson, L. Koymans, T. Kamataki, J.J. Stegeman, R. Feyereisen, D.J. Waxman, M.R. Waterman, O. Gotoh, M.J. Coon, R.W. Estabrook, I.C. Gunsalus, and D.W. Nebert P-450 superfamily: update on new sequence, gene mapping, accession numbers and nomenclature Pharmacogenetics 6 1996 1 42
2. F. Pons, M. Haag, A. Lugnier, and N. Frossard Cytochrome P450 in the lung Eur. Respir. Rev. 10 2000 253 256
3. V. Longo, M. Ingelman-Sundberg, G. Amato, A. Salvetti, and P.G. Gervasi Effect of starvation and chlormethiazole on cytochrome P450s of rat nasal mucosa Biochem. Pharmacol. 59 2000 1425 1432
4. I. Fleming Cytochrome P450 enzymes in vascular homeostasis Circ. Res. 89 2001 753 762
5. J.W. Lohr, G.R. Willsky, and M.A. Acara Renal drug metabolism Pharmacol. Rev. 50 1998 107 141
6. D.C. Zeldin Epoxygenase pathways of arachidonic acid metabolism J. Biol. Chem. 276 2001 36059 36062
7. J.H. Capdevila, R.C. Harris, and J.R. Falck Microsomal cytochrome P450 and eicosanoid metabolism Cell. Mol. Life Sci. 59 2002 780 789
8. B. Fisslthaler, N. Hinsch, T. Chataigneau, R. Popp, L. Kiss, R. Busse, and I. Fleming Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries Hypertension 36 2000 270 275
9. K. Node, Y. Huo, X. Ruan, B. Yang, M. Spiecker, K. Ley, D.C. Zeldin, and J.K. Liao Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 1999 1276 1279
10. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, I. Fleming, and R. Busse Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
11. M. Hacker, A.T. Bara, J. Bauersachs, and R. Busse Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P-450-derived arachidonic acid metabolite in mammals J. Physiol. 481 1994 407 414
12. M. Rosolowsky, and W.B. Campbell Role of PGI2 and epoxyecosatrienoic acid in relaxation of bovine coronary arteries to arachidonic acid Am. J. Physiol. 264 1993 H327 H335
13. J. Borlak, M. Walles, K. Levsen, and T. Thum Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells Drug Metab. Dispos. 31 2003 888 891
14. S. Sivapathasundaram, P. Magnisali, N.G. Coldham, L.C. Howells, M.J. Sauer, and C. Ioannides A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver Biochem. Pharmacol. 62 2001 635 645
15. V. Longo, A. Mazzaccaro, F. Naldi, and P.G. Gervasi Drug-metabolizing enzymes in liver, olfactory, and respiratory epithelium of cattle J. Biochem. Toxicol. 6 1991 123 128
16. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
17. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
18. T. Omura, and R. Sato The carbon-monoxide binding protein of liver microsomes: I. Evidence for its hemoprotein nature J. Biol. Chem. 239 1964 2370 2378
19. B.S.S. Masters Jr., C.H. William, and H. Kamin The preparation and properties of microsomal NADPH-cytochrome c reductase from pig liver R.W. Estabrook E.E. Pulman Methods in Enzymology vol. 10 1967 Academic Press New York 565 573
20. K.R. Krijgsheld, and T.E. Gram Selective induction of renal microsomal cytochrome P-450-linked monooxygenases by 1,1-dichloroethylene in mice Biochem. Pharmacol. 33 1984 1951 1956
21. A. Ghosal, N. Hapangama, Y. Yuan, L.V. Favreau, J.R. Palamanda, J.E. Partick, M.N. Cayen, and S. Zbaida Microtiter plate-based assay for rapid determination of enzyme activities of 13 P-450 supersomes and human liver microsomes Drug Metab. Rev. 32 2000 188
22. S. Ekins, M. VandenBranden, B.J. Ring, and S.A. Wrighton Examination of purported probes of human CYP2B6 Pharmacogenetics 7 1997 165 179
23. D.M. Stresser, A.P. Blanchard, S.D. Turner, J.C. Erve, A.A. Dandeneau, V.P. Miller, and C.L. Crespi Substrate-dependent modulation of CYP3A catalytic activity: analysis of 27 test compounds with four fluorimetric substrates Drug Metab. Dispos. 28 2000 1440 1448
24. A. Aitio A simple and sensitive assay of 7-ethoxycoumarin deethylation Anal. Biochem. 85 1978 488 491
25. S. Ono, T. Hatanaka, H. Hotta, T. Satoh, F.J. Gonzalez, and M. Tsutsui Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes Xenobiotica 26 1996 681 693
26. M. Rosolowsky, and W.B. Campbell Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells Biochim. Biophys. Acta 1299 1996 267 277
27. D.W. Nebert Drug-metabolising enzymes in ligand-modulated transcription Biochem. Pharmacol. 47 1994 25 37
28. E.R. Jacobs, and D.C. Zeldin The lung HETEs (and EETs) up Am. J. Phys. 260 2001 H1 H10
29. B.Y. Yang, L. Graham, S. Dikalov, R.P. Mason, J.R. Falk, J.K. Liao, and D.C. Zeldin Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells Mol. Pharmacol. 60 2001 310 320
30. D.F. Lewis Quantitative structure-activity relationships in substrates, inducers, and inhibitors of cytochrome P4501 (CYP1) Drug Metab. Rev. 29 1997 589 650
31. F.P. Guengerich, D.H. Kim, and M. Iwasaki Role of human cytochrome P4502E1 in the oxidation of many low molecular weight cancer suspects Chem. Res. Toxicol. 4 1991 168 179
32. A.A. Caro, and A.I. Cederbaum Oxidative stress, toxicology and pharmacology of CYP 2E1 Annu. Rev. Pharmacol. Toxicol. 44 2004 27 42
33. T. Finkel Oxygen radical and signaling Curr. Opin. Cell Biol. 10 1998 248 253